At present, the Nigerian Centre for Disease Control (NCDC) is creating a Monkeypox Vaccine. It is in the clinical trials stage and is expected to be licensed for use in Nigeria by July 202 The vaccine is a combination of two different parts that are both composed of a weakened form of a related virus, Vaccinia.
This type of vaccine called MVA85A is both safe and effective against infection.